Dr. Marta Mellai

Marta Mellai is a geneticist currently appointed as a research scientist at the Genomics Core Facility at the Excellence Research Center for Autoimmune and Allergic Disease (CAAD) at the University of Piemonte Orientale (UPO, IT).  She attained an MD in Biological Sciences at the University of Pavia (UNIPV, 1998), a PhD in Molecular Medicine at UPO (2003), and a postgraduate school qualification in “Clinical Pathology and Clinical Biochemistry” at UNIPV (2022).  She is a researcher with >20 years of experience in neuroscience (>70 articles and 10 book chapters). Previous interests were focused on research projects on new possible biomarkers for standard care improvement in CNS tumors (gliomas and meningiomas), colonadenocarcinoma, melanoma.  Current research is focused on “omics” technologies, including genomics, transcriptomics, and metagenomics (16S/shotgun NGS) in eukaryotics or prokaryotics under pathologic conditions (IBDs, multiple sclerosis, psoriasis, and gut dysbiosis).  Peer review activity for indexed journals and research projects from international charities.